VIR vs. CRT
Compare and contrast key facts about Vir Biotechnology, Inc. (VIR) and Cross Timbers Royalty Trust (CRT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VIR or CRT.
Key characteristics
| VIR | CRT | |
|---|---|---|
| YTD Return | -21.77% | -43.69% |
| 1Y Return | -19.86% | -54.13% |
| 3Y Return (Ann) | -47.73% | -2.21% |
| Sharpe Ratio | -0.38 | -1.42 |
| Daily Std Dev | 57.08% | 38.96% |
| Max Drawdown | -90.85% | -83.46% |
| Current Drawdown | -90.53% | -64.41% |
Fundamentals
| VIR | CRT | |
|---|---|---|
| Market Cap | $1.08B | $55.56M |
| EPS | -$3.58 | $1.28 |
| Total Revenue (TTM) | $72.14M | $8.66M |
| Gross Profit (TTM) | $57.94M | $14.46M |
| EBITDA (TTM) | -$469.73M | $5.39M |
Correlation
The correlation between VIR and CRT is 0.01, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
VIR vs. CRT - Performance Comparison
In the year-to-date period, VIR achieves a -21.77% return, which is significantly higher than CRT's -43.69% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
VIR vs. CRT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Vir Biotechnology, Inc. (VIR) and Cross Timbers Royalty Trust (CRT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
VIR vs. CRT - Dividend Comparison
VIR has not paid dividends to shareholders, while CRT's dividend yield for the trailing twelve months is around 11.83%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VIR Vir Biotechnology, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CRT Cross Timbers Royalty Trust | 11.83% | 10.96% | 7.69% | 9.71% | 9.46% | 10.04% | 13.06% | 6.87% | 5.90% | 10.41% | 15.34% | 7.87% |
Drawdowns
VIR vs. CRT - Drawdown Comparison
The maximum VIR drawdown since its inception was -90.85%, which is greater than CRT's maximum drawdown of -83.46%. Use the drawdown chart below to compare losses from any high point for VIR and CRT. For additional features, visit the drawdowns tool.
Volatility
VIR vs. CRT - Volatility Comparison
Vir Biotechnology, Inc. (VIR) has a higher volatility of 11.76% compared to Cross Timbers Royalty Trust (CRT) at 7.47%. This indicates that VIR's price experiences larger fluctuations and is considered to be riskier than CRT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
VIR vs. CRT - Financials Comparison
This section allows you to compare key financial metrics between Vir Biotechnology, Inc. and Cross Timbers Royalty Trust. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities